Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis

INTRODUCTION: Proliferative lupus nephritis (LN) progresses to end-stage kidney disease (ESKD) in roughly 10% of the cases despite treatment. Other than achieving <0.8 g/24h proteinuria at 12 months after treatment, early biomarkers predicting ESKD or death are lacking. Recent studies encompassin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Giovanni Maria, Maggiore, Umberto, Peyronel, Francesco, Fenaroli, Paride, Delsante, Marco, Benigno, Giuseppe Daniele, Gianfreda, Davide, Urban, Maria Letizia, Manna, Zerai, Arend, Lois Johanna, Bagnasco, Serena, Vaglio, Augusto, Fiaccadori, Enrico, Rosenberg, Avi Z., Hasni, Sarfaraz, Manenti, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727529/
https://www.ncbi.nlm.nih.gov/pubmed/36506236
http://dx.doi.org/10.1016/j.ekir.2022.09.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727529/
https://www.ncbi.nlm.nih.gov/pubmed/36506236
http://dx.doi.org/10.1016/j.ekir.2022.09.012

Ejemplares similares